Biotech and Pharmaceuticals

Pancreatic cancer, illustration Nemes Laszl | Science Photo Library | Getty Images Revolution Medicines‘ drug for pancreatic cancer…

Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the…

Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…

A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters…

Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…

Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…

Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…

A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters…

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…

Pancreatic cancer drug daraxonrasib from Revolution Medicines succeeds in trial